0DUE4KZ
Supplement Large Intestine to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | D Gastrointestinal System |
| Operation | U Supplement |
| Body Part | E Large Intestine |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a gastrointestinal structure that remains in place, rather than removing or replacing it. The most familiar example is hernia repair using mesh, where the natural tissue defect is closed and then bolstered with a synthetic patch to reduce the chance of recurrence, but the category also includes reinforcement of a weakened rectal wall or augmentation of tissue around a stoma to improve support.
This approach is chosen when the underlying organ is structurally sound enough to remain but needs extra strength or bulk to function reliably going forward. It differs fundamentally from procedures that cut away diseased tissue, since the native anatomy stays intact and the added material works alongside it rather than substituting for it.
Anatomy & Axis Detail
Large Intestine
When "Large Intestine" is coded generically for Supplement, the procedure augments a portion of colon whose native wall is intact but weakened, thinned, or structurally compromised without being confined to one of the named colonic segments. This might occur with diffuse serosal reinforcement during extensive adhesiolysis, patch repair over multiple contiguous segments, or buttressing of a long staple or suture line spanning more than one region. The colon's thin muscularis and dependence on serosal integrity for containment make reinforcement clinically meaningful for reducing leak or dehiscence risk. Documentation should specify the material used, whether autologous, nonautologous, or synthetic, and clarify that the procedure addresses tissue that is present but deficient rather than absent, distinguishing it from repair, replacement, or segment-specific supplement codes.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders should confirm that the operative note describes material being added to reinforce or augment existing tissue that was not removed, with the specific material named, such as polypropylene mesh or a biologic graft. Supplement frequently appears alongside Repair in hernia surgery, and the two must be sequenced or combined correctly depending on whether the defect closure and reinforcement are described as a single combined objective or separate steps. A common error is coding a mesh-reinforced repair purely as Repair, omitting the Supplement component, or conversely coding Supplement when the mesh was actually used to bridge a defect where tissue was removed, which would instead point toward Replacement. Documentation should also clarify the approach, since mesh placement can occur open, laparoscopically, or via a percutaneous endoscopic technique.